We proudly delivered Moderna’s state-of-the-art clinical laboratories as part of the Moderna Innovation and Technology Centre (MITC) at Harwell Campus, Oxfordshire. This landmark facility, the first of its kind for Moderna in the UK, strengthens the nation’s vaccine development and research capabilities, bringing cutting-edge science closer to home.

For Merit, this project was a significant milestone, marking the first deployment of our innovative UltraPOD®+ solution.

This new facility is more than just a building — it’s a vital part of the UK’s ongoing resilience against future pandemics. It empowers researchers with the tools they need to advance groundbreaking mRNA vaccine research, which played a crucial role in combating COVID-19, ensuring the country remains at the forefront of global health innovations.